Phenotypic modulation of Hodgkin and Reed-Sternberg cells by Epstein-Barr virus

Journal of Pathology

Volumn 179, Issue 1, 1996, Pages 54-59

  Herbst, Hermann ^a,b   Raff, Thorsten ^a   Stein, Harald ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Activation antigens; B cell antigens; Epstein Barr virus; Hodgkin and Reed Sternberg cells; Hodgkin's disease; Immunohistochemistry; Immunophenotype; T cell antigens

Indexed keywords

CD20 ANTIGEN; CD30 ANTIGEN;

ARTICLE; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REED STERNBERG CELL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; REED-STERNBERG CELLS; SEX DISTRIBUTION; TUMOR VIRUS INFECTIONS; VIRAL MATRIX PROTEINS;

EID: 0029937033     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199605)179:1<54::AID-PATH537>3.0.CO;2-2     Document Type: Article

References (37)

1. Khan G, Coats PJ The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease J Pathol 1994; 174: 141-149.
2. Herbst H, Niedobitek G. Epstem-Barr virus in Hodgkin's disease. EBV Rep 1994, 1: 31-35.
3. Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107-1115.
4. Torsteinsdottir S, Brautbar C, Ben Basset H, Klein E, Klein G. Differential expression of HLA antigens on human B cell lines of normal and malignant origin: consequence of immune surveillance or a phenotype vestige of the progenitor cells? Int J Cancer 1988; 41: 913-919.
5. Andersson ML, Stam J, Klein G, et al. Aberrant expression of HLA class I antigens in Burkitt lymphoma cells. Int J Cancer 1991; 47: 544-550
6. Rowe M, Rowe DT, Gregory CD, et al. Differences in B cell growth phenotype reflect novel patterns of Epstem-Barr virus latent gene expression in Burkitt's lymphoma cells EMBO J 1987; 6: 2743-2751
7. Isaacson PG, Schmid C, Pan L, Wotherspoon AC, Wright DH. Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis. J Pathol 1992; 167: 267-271.
8. Foss HD, Herbst H, Hummel M, et al. Patterns of cytokine gene expression in infectious mononucleosis. Blood 1994; 83: 707-712.
9. Hamilton-Dutoit SJ, Rea D, Raphael M, et al Epstein-Barr virus latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency Am J Pathol 1993; 143: 1072-1085.
10. Calender A, Cordier M, Billaud M, Lenoir GM Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus Int J Cancer 1990, 46: 658-663.
11. Dawson CW, Rickinson AB, Young LS Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990; 344: 777-780.
12. Niedobitek G, Fahraeus R, Herbst H, et al. The Epstein-Barr virus encoded membrane protein (LMP) induced phenotypic changes in epithelial cells. Virchows Arch B [Cell Pathol] 1992, 62: 555-559
13. Herbst H, Steinbrecher E, Niedobitek G, et al. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease Blood 1992; 80: 484-491.
14. Bai MC, Jiwa HN, Horstman A, et al. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease. J Pathol 1994, 174: 49-55.
15. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84: 1361-1392
16. Stein H, Gatter K, Asbahr H, Mason DY. Use of freeze-dried paraffin embedded sections for immunohistological staining with monoclonal antibodies Lab Invest 1985, 52: 676-683.
17. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966, 26: 1189-1200.
18. Correa P, O'Connor GT. Epidemiologic patterns of Hodgkin's disease. Int J Cancer 1971, 8: 192-201
19. Gutensohn N, Cole P. Epidemiology of Hodgkin's disease. Semin Oncol 1980, 7: 92-102
20. Khan G, Norton AJ, Slavin G Epstem-Barr virus in Hodgkin's disease: relation to age and subtype. Cancer 1993; 71: 3124-3129
21. Armstrong AA, Alexander FE, Paes RP, et al Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993; 142: 1683-1688.
22. Jarrett RF, Gallagher A, Jones DB, et al. Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin Pathol 1991; 44: 844-848.
23. Weinreb M, Day PJR, Muray PG, et al. Epstein Barr virus (EBV) and Hodgkin's disease in children incidence of latent membrane protein in malignant cells. J Pathol 1992; 168: 365-369.
24. Vesttlev PM, Pallesen G, Sandvej K, et al. Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein. Int J Cancer 1992; 50: 670-671.
25. Hugh J, Poppema S. Immunophenotype of Reed-Sternberg cells. Int Rev Exp Pathol 1992; 33: 81-114.
26. Herbst H, Stein H, Niedobitek G Epstein-Barr virus and CD30-positive malignant lymphomas. Crit Rev Oncog 1993; 4: 191-239.
27. Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymph 1992; 8: 283-313
28. Haluska FG, Brufsky AM, Canellos GP. The cellular biology of the Reed-Sternberg cell. Blood 1994; 84: 1005-1019.
29. Herbst H, Dallenbach F, Hummel M, et al. Epstein-Barr virus latent membrane antigen expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 1991; 88: 4766-4770
30. Palleseu G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320-322
31. Niedobitek G, Rowlands DC, Young LS, et al Overexpression of p53 in Hodgkin's disease: lack of correlation with Epstein-Barr virus infection. J Pathol 1993; 169: 207-212.
32. Stein H, Mason DY, Gerdes J, et al. The expression of Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue. Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 849-858.
33. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. The Epstetn-Barr virus transforming protein LMP1 engages signalling proteins for the tumor necrosis factor receptor family Cell 1995; 80: 389-399.
34. Rowe M, Peng-Pilon M, Huen DS, et al. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP-1: a B-cell-specific response that is delayed relative to NF-κB activation and to induction of cell surface markers. J Virol 1994; 68: 5602-5612.
35. Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor κB. J Biol Chem 1992; 267: 24157-24160.
36. Delsol G, Gatter KC , Stein H, et al Human lymphoid cells express epithelial membrane antigen. Implications for the diagnosis of human neoplasms Lancet 1984; 2: 1124-1128
37. Delsol G, Al Saati T, Gatter KC, et al Coexpression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell limphomas Diagnostic value in so-called malignant histiocytosis Am J Pathol 1988, 130: 59-70.